B-CELL LYMPHOMA RECURRENT
Clinical trials for B-CELL LYMPHOMA RECURRENT explained in plain language.
Never miss a new study
Get alerted when new B-CELL LYMPHOMA RECURRENT trials appear
Sign up with your email to follow new studies for B-CELL LYMPHOMA RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat lymphoma in the brain: drug combo trial launches
Disease control Recruiting nowThis study tests a new drug, selinexor, combined with standard chemotherapy for people with B-cell lymphoma that has returned or not responded to treatment and has spread to the brain or spinal cord. The goal is to see if the combination is safe and effective. About 37 adults wil…
Matched conditions: B-CELL LYMPHOMA RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated May 01, 2026 14:58 UTC
-
Engineered immune cells take on tough lymphoma in new trial
Disease control Recruiting nowThis study tests a treatment called TranspoCART19 for people with B-cell lymphoma that has returned or not responded to standard therapy. The treatment uses a patient's own immune cells, which are modified in a lab to better recognize and attack cancer cells. The main goals are t…
Matched conditions: B-CELL LYMPHOMA RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: Instituto de Investigación Biomédica de Salamanca • Aim: Disease control
Last updated May 01, 2026 14:58 UTC